Pulmonary Disease Clinical Trials in London
18 recruitingLondon, United Kingdom
Showing 1–18 of 18 trials
Recruiting
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
Pulmonary Disease, Chronic Obstructive
AstraZeneca2,000 enrolled7 locationsNCT06712563
Recruiting
Phase 2
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca987 enrolled366 locationsNCT07082738
Recruiting
Investigating Health Related Quality of Life in Patients With Chronic Respiratory Failure
Chronic Obstructive Pulmonary DiseaseRespiratory FailureNeuromuscular Diseases+1 more
Guy's and St Thomas' NHS Foundation Trust200 enrolled1 locationNCT04236726
Recruiting
Phase 4
A Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
Chronic Obstructive Pulmonary DiseaseHyperinflation
AstraZeneca56 enrolled7 locationsNCT07073950
Recruiting
Phase 3
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche2,000 enrolled486 locationsNCT05878769
Recruiting
The CATALINA Study
Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens1,000 enrolled22 locationsNCT05008081
Recruiting
Health Impact of Non-Tuberculous Mycobacteria Pulmonary Disease (NTM-PD)
BronchiectasisNon-Tuberculous Mycobacteria Pulmonary Disease
University College, London80 enrolled1 locationNCT07192705
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled920 locationsNCT06283966
Recruiting
Phase 2Phase 3
Finding the Optimal Regimen for Mycobacterium Abscessus Treatment
Pulmonary Disease Due to Mycobacteria (Diagnosis)
The University of Queensland300 enrolled50 locationsNCT04310930
Recruiting
Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Develop Novel Therapies and Therapeutic Targets
COPD, Chronic Obstructive Pulmonary DiseaseExacerbation of COPDRhinovirus Infection
Imperial College London50 enrolled1 locationNCT07112235
Recruiting
Phase 3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline960 enrolled159 locationsNCT06961214
Recruiting
Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche1,290 enrolled462 locationsNCT05595642
Recruiting
Phase 4
Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil Levels
Chronic Obstructive Pulmonary Disease
Maria Joyera Rodríguez135 enrolled6 locationsNCT06334575
Recruiting
Phase 1
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline130 enrolled32 locationsNCT06154837
Recruiting
Exploring How Viral Infections Affect People With Chronic Lung Disease
COPD, Chronic Obstructive Pulmonary DiseaseBronchiectasis with Acute ExacerbationBronchiectasis Adult+1 more
Imperial College London180 enrolled1 locationNCT06625944
Recruiting
Not Applicable
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
Lung CancerAsthmaChronic Obstructive Pulmonary Disease+5 more
King's College Hospital NHS Trust246 enrolled1 locationNCT06326957
Recruiting
PASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A.25,000 enrolled1 locationNCT05652439
Recruiting
The London COPD Exacerbation Cohort
Pulmonary Disease, Chronic Obstructive
Imperial College London300 enrolled1 locationNCT02755974